Genflow Biosciences Plc (GB:GENF) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Genflow Biosciences Plc, a biotech firm specializing in longevity research, has received a €395,847 grant from the Government of Wallonia to fund its Exofastrack research program. The grant will cover 80% of the program’s expenses, aiding the development of an innovative exosome therapy targeting liver fibrosis and Werner Syndrome. CEO Dr. Eric Leire expressed excitement over the grant’s potential to accelerate their pioneering work in exosome-based treatments for age-related diseases.
For further insights into GB:GENF stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “…Tied to the Effort From the Administration” Boeing Stock (NYSE:BA) Blasts Up as Boeing Counts on New Top Sales Rep in China: President Trump
- “We Do Not Have Conflicting Interests….” Microsoft Stock (NASDAQ:MSFT) Gains on New Plan to be the Agentic AI Internet’s Backbone
- Battery Business Suddenly Goes South, Tesla Stock (NASDAQ:TSLA) Notches Up